Association Between ABCB1 (MDR1) Gene Polymorphism and Unresponsiveness Combined Therapy in Chronic Hepatitis C virus


Timucin M., Alagozlu H., ÖZDEMİR S., Ozdemir O.

HEPATITIS MONTHLY, vol.13, no.4, 2013 (Peer-Reviewed Journal) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 13 Issue: 4
  • Publication Date: 2013
  • Doi Number: 10.5812/hepatmon.7522
  • Journal Name: HEPATITIS MONTHLY
  • Journal Indexes: Science Citation Index Expanded, Scopus
  • Keywords: Hepatitis C, Data Collection, P Glycoprotein, HUMAN HEPATOCELLULAR-CARCINOMA, MULTIDRUG-RESISTANCE, CLINICAL-OUTCOMES, CANCER CELLS, EXPRESSION, GENOTYPE, ALPHA, DRUG, CHEMOTHERAPY, INFECTION

Abstract

Background: To treat viral infection of chronic hepatitis C (CHC) is a main strategy to prevent progression of liver disease, and cancer. Some patients with CHC have failed to respond to the common antiviral therapy in different populations.